Market Access

We optimize the interaction within the supply chain in the pharmaceutical market, eliminating unnecessary links and replacing them with advanced technologies

Cash-back Service

We develop a loyalty system, promote the commitment of people to a healthy lifestyle and help ultimate buyers to reduce the costs for pharmaceutical goods by 10-15%

Online Learning

Thanks to online training platforms for pharmaceutical specialists, we improve the quality of pharmaceutical care for people

RUSSIA & CIS

In the market since 2016

Value of the pharmaceutical market – $17 billion (as of 2018)

65,000 pharmacies

Share of pharmacies in the region using the company's products – 21%

MENA

In the market since 2019

Market value – $66 billion

125,000 pharmacies

Expected share of pharmacies in the region using the company's products* – 20%

*Time frame – 3 years

Home RUSSIA & CIS

MENA

The market, which includes over 20 countries of the Middle East and North Africa, is considered to be one of the most dynamic markets in the global pharmaceutical industry. According to analysts, it will grow to $100 billion in the coming years already. Pharma.Global has been supplying its products to the MENA market since 2019.

Market

Value
$66 billion
125,000
pharmacies
320
pharmaceutical companies
25,000 — 20% of the market (forecast for 3 years)
expected number of pharmacies in the region using the company's products
150 — 46% of the market
expected number of partner pharmaceutical companies

Products

PharmaCourse is an online learning platform for pharmaceutical professionals. Thanks to the resource, they get access to modern scientific knowledge and industry expertise and can improve their skills on the job, at a time and place of their choosing.

Pharma.Course

PharmMarket is a pharmaceutical marketplace that allows pharmaceutical companies to enter into direct contracts with pharmacies.

PharmaBonus is a loyalty program, thanks to which pharmaceutical consumers get cash-back (a refund of part of the purchase amount) directly from pharmaceutical manufacturers.